Malignant Brain Neoplasm
22
14
16
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
4.5%
1 terminated out of 22 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (22)
An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
Cancer Genetic Testing in Ethnic Populations
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
Intravital Microscopy in Human Solid Tumors
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Defining Musical Toxicity and Its Effect on Patient Well-being
Feasibility of FMISO in Brain Tumors
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases